查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1659414

全球分子品管市場

Molecular Quality Controls
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球分子品管市場規模將達到 3.199 億美元

2024 年全球分子品管市場規模估計為 2.382 億美元，預計 2030 年將達到 3.199 億美元，2024 年至 2030 年的複合年成長率為 5.0%。獨立控制是報告中分析的細分市場之一，預計在分析期結束時複合年成長率為 5.4%，達到 2.113 億美元。在分析期內，控制設備部分的成長率預計將達到 4.4% 的複合年成長率。

美國市場規模估計為 6,550 萬美元，中國市場預估年複合成長率為 4.7%

預計2024年美國分子品管市場價值將達到 6,550 萬美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 5,000 萬美元，2024-2030 年分析期間的複合年成長率為 4.7%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 4.7% 和 3.8%。在歐洲，德國的複合年成長率預計為 3.9%。

全球分子品管市場 - 主要趨勢與促進因素摘要

分子品管如何影響診斷的準確性？

分子品管透過確保分子診斷測試的準確性、可靠性和一致性在臨床實驗室和診斷中心發揮著至關重要的作用。這些控制用於監測核酸檢測程序（包括 PCR、NGS 和其他分子檢測）的性能，以確保檢測結果的有效性。它可以幫助實驗室遵守監管要求、維持高品質標準並檢測診斷工作流程中的潛在問題。隨著分子診斷在醫療保健中變得越來越重要，對嚴格品管的需求也隨之增加。分子品管的應用涉及多個領域，包括傳染病檢查、腫瘤學、基因檢測和個人化醫療。隨著癌症和感染疾病等疾病變得越來越普遍，分子診斷測試變得越來越複雜，需要加強品管。分子品管確保診斷檢測提供準確的結果，改善患者的治療效果並增強醫療服務。

哪些趨勢正在塑造分子品管市場？

影響分子品管市場的關鍵趨勢包括分子診斷的快速進步、個人化醫療的日益普及以及對實驗室業務法規遵從性的日益重視。即時PCR和次世代定序(NGS) 等分子診斷技術創新導致了更複雜的測試過程，需要嚴格的品管以確保可靠的性能。市場也越來越關注個人化醫療，準確的分子檢測對於根據個別患者制定治療方案至關重要。 FDA 和 CLIA 等監管機構要求在分子診斷中使用品管來確保測試結果的準確性和可重複性。這種監管環境正在推動實驗室和診斷中心採用分子品管。此外，感染疾病和癌症的蔓延推動了對分子診斷的需求，進一步增加了對品管以維持高檢測標準的需求。

市場區隔將如何影響分子品管？

產品類型包括獨立控制、儀器特定控制和分析物特定控制，其中獨立控制越來越受歡迎，因為它們能夠檢驗整個測試過程。應用包括傳染病檢查、腫瘤學檢測和基因檢測，其中由於 COVID-19、流感等的檢測數量很大，感染疾病診斷佔很大比例。分子品管的最終用戶包括診斷實驗室、醫院、研究機構和學術中心。由於臨床護理對分子測試的需求很高，診斷實驗室是最大的終端使用者群體。從地區來看，北美由於其先進的醫療基礎設施、法規合規要求以及慢性病的高發性而佔據市場主導地位。由於醫療保健投資的增加和分子診斷的應用不斷增加，亞太地區正在經歷快速成長。

哪些因素推動了分子品管市場的成長？

分子品管市場的成長受到多種因素的推動，包括分子診斷的應用日益廣泛、檢測技術的進步以及品質保證的嚴格監管要求。對於準確、可靠的診斷測試的需求推動了分子品管的需求。 NGS 和數位 PCR 等技術創新為開發更複雜的品管解決方案創造了機會。此外，對個人化醫療的日益關注以及感染疾病和癌症發病率的上升進一步加速了市場的成長。

部分

產品類型（獨立控制、基於儀器的控制）；分析物類型（單分析物控制、多分析物控制）；應用（感染疾病、癌症、基因檢測、其他應用）

受訪公司範例（值得關注的33家公司）

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Helena Biosciences Europe
  • Maine Molecular Quality Controls, Inc.
  • Microbiologics, Inc.
  • Qnostics
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • SeraCare Life Sciences, Inc.
  • SERO AS
  • Technopath Clinical Diagnostics
  • Thermo Fisher Scientific Inc.
  • ZeptoMetrix Corporation

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP22324

Global Molecular Quality Controls Market to Reach US$319.9 Million by 2030

The global market for Molecular Quality Controls estimated at US$238.2 Million in the year 2024, is expected to reach US$319.9 Million by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Independent Controls, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$211.3 Million by the end of the analysis period. Growth in the Instrument-Specific Controls segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$65.5 Million While China is Forecast to Grow at 4.7% CAGR

The Molecular Quality Controls market in the U.S. is estimated at US$65.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$50.0 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.7% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Molecular Quality Controls Market - Key Trends and Drivers Summarized

How Are Molecular Quality Controls Shaping Diagnostic Accuracy?

Molecular quality controls play a crucial role in clinical laboratories and diagnostic centers by ensuring the accuracy, reliability, and consistency of molecular diagnostic tests. These controls are used to monitor the performance of nucleic acid testing procedures, including PCR, NGS, and other molecular assays, ensuring the validity of test results. They help laboratories comply with regulatory requirements, maintain high-quality standards, and detect any potential issues in diagnostic workflows. As molecular diagnostics become increasingly essential in healthcare, the need for stringent quality controls has intensified. The application of molecular quality controls spans across various domains such as infectious disease testing, oncology, genetic testing, and personalized medicine. With the rising prevalence of diseases such as cancer and infectious conditions, molecular diagnostic tests are becoming more sophisticated, demanding enhanced quality control measures. Molecular quality controls ensure that the diagnostic assays produce accurate results, leading to better patient outcomes and improved healthcare services.

What Trends Are Shaping the Molecular Quality Controls Market?

Key trends influencing the molecular quality controls market include the rapid advancements in molecular diagnostics, the increasing adoption of personalized medicine, and the growing emphasis on regulatory compliance in laboratory practices. Technological innovations in molecular diagnostics, such as real-time PCR and next-generation sequencing (NGS), have led to more complex testing processes, which require stringent quality controls to ensure reliable performance. The market is also witnessing an increased focus on personalized medicine, where accurate molecular testing is crucial for tailoring treatments to individual patients. Regulatory agencies such as the FDA and CLIA mandate the use of quality controls in molecular diagnostics to ensure the accuracy and reproducibility of test results. This regulatory landscape is driving the adoption of molecular quality controls across laboratories and diagnostic centers. Additionally, the increasing prevalence of infectious diseases and cancer is propelling demand for molecular diagnostics, further boosting the need for quality controls to maintain high testing standards.

How Do Market Segments Impact the Molecular Quality Controls Landscape?

Product types include independent controls, instrument-specific controls, and analyte-specific controls, with independent controls gaining popularity due to their ability to validate the entire testing process. Applications encompass infectious disease testing, oncology testing, and genetic testing, with infectious disease diagnostics accounting for a significant share due to the high volume of tests conducted for conditions like COVID-19 and influenza. End-users of molecular quality controls include diagnostic laboratories, hospitals, research institutions, and academic centers. Diagnostic laboratories represent the largest end-user segment due to the high demand for molecular testing in clinical settings. Geographically, North America dominates the market due to advanced healthcare infrastructure, regulatory compliance requirements, and a high prevalence of chronic diseases. The Asia-Pacific region is witnessing rapid growth due to increased healthcare investments and the rising adoption of molecular diagnostics.

What Factors Are Driving the Growth in the Molecular Quality Controls Market?

The growth in the molecular quality controls market is driven by several factors, including the increasing adoption of molecular diagnostics, advancements in testing technologies, and stringent regulatory requirements for quality assurance. The demand for accurate and reliable diagnostic tests is fueling the need for molecular quality controls. Technological innovations such as NGS and digital PCR are creating opportunities for the development of more sophisticated quality control solutions. Additionally, the growing focus on personalized medicine and the rising prevalence of infectious diseases and cancer are further accelerating market growth.

SCOPE OF STUDY:

The report analyzes the Molecular Quality Controls market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Independent Controls, Instrument-Specific Controls); Analyte Type (Single-Analyte Controls, Multi-Analyte Controls); Application (Infectious Diseases, Oncology, Genetic Testing, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 33 Featured) -

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Helena Biosciences Europe
  • Maine Molecular Quality Controls, Inc.
  • Microbiologics, Inc.
  • Qnostics
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • SeraCare Life Sciences, Inc.
  • SERO AS
  • Technopath Clinical Diagnostics
  • Thermo Fisher Scientific Inc.
  • ZeptoMetrix Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Molecular Quality Controls - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Accuracy and Reliability in Molecular Diagnostics Spurs Growth in Molecular Quality Controls Market
    • Technological Advancements in High-Sensitivity and Multi-Analyte Quality Controls Strengthen Business Case for Adoption
    • Expansion of Molecular Quality Controls in Infectious Disease Testing and Oncology Fuels Market Growth
    • Increasing Adoption of Molecular Quality Controls in Clinical Laboratories and Diagnostic Centers Expands Market Opportunities
    • Technological Innovations in Next-Generation Sequencing (NGS) and Polymerase Chain Reaction (PCR) Controls Propel Market Expansion
    • Rising Focus on Enhancing Diagnostic Accuracy and Reducing False-Positive Rates Drives Demand for Molecular Quality Controls
    • Growing Use of Molecular Quality Controls in Genetic Testing and Personalized Medicine Expands Market Potential
    • Focus on Reducing Laboratory Errors and Enhancing Workflow Efficiency Strengthens Market for Molecular Quality Controls
    • Technological Advancements in Digital and Automated Quality Control Systems Propel Market Growth
    • Rising Demand for Molecular Quality Controls in Point-of-Care Testing (POCT) Strengthens Global Market
    • Expansion of Molecular Quality Controls in Biopharmaceutical and Research Applications Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Molecular Quality Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Molecular Quality Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Molecular Quality Controls by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Independent Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Independent Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Independent Controls by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Instrument-Specific Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Instrument-Specific Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Instrument-Specific Controls by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Single-Analyte Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Single-Analyte Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Single-Analyte Controls by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Multi-Analyte Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Multi-Analyte Controls by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Multi-Analyte Controls by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Molecular Quality Controls Market Analysis of Annual Sales in US$ for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Molecular Quality Controls Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Molecular Quality Controls Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Molecular Quality Controls Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Molecular Quality Controls Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Molecular Quality Controls by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Molecular Quality Controls by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Molecular Quality Controls by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Molecular Quality Controls Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Molecular Quality Controls Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Molecular Quality Controls Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Molecular Quality Controls Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Molecular Quality Controls by Product - Independent Controls and Instrument-Specific Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of World 15-Year Perspective for Molecular Quality Controls by Product - Percentage Breakdown of Value Sales for Independent Controls and Instrument-Specific Controls for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Molecular Quality Controls by Analyte Type - Single-Analyte Controls and Multi-Analyte Controls Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of World 15-Year Perspective for Molecular Quality Controls by Analyte Type - Percentage Breakdown of Value Sales for Single-Analyte Controls and Multi-Analyte Controls for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Molecular Quality Controls by Application - Infectious Diseases, Oncology, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for Molecular Quality Controls by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Oncology, Genetic Testing and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION